Jamil Khurram Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$12,044.19

Insider Activity of Jamil Khurram

According to the SEC Form 4 filings, Jamil Khurram, being in a position of

  1. Chief Medical Officer at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 208750 shares for $1M,
    over all time since 2024-12-23, has bought 0 shares, and sold 222404 shares for $1.01M.

Biography of Jamil Khurram

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,001,89711100

Comparison of Insiders on Amount of Buys and Sells

2026-07-14SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
16,250
0.0237%
$5.13$83,285-31.09%
2026-06-29SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
47,467
0.0731%
$5.04$239,234-24.95%
2026-06-26SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
2,533
0.0039%
$5.00$12,665-24.95%
2026-06-23SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
7,557
0.0115%
$3.14$23,729+20.51%
2026-05-26SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
568
0.001%
$3.10$1,761+31%
2026-01-06SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
21,446
0.0313%
$3.65$78,205-9.13%
2026-01-05SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
25,499
0.0398%
$3.90$99,408-19.07%
2026-01-02SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
13,055
0.0205%
$4.20$54,789-22.47%
2025-12-31SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
8,125
0.0126%
$4.07$33,089-24.52%
2025-12-17SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
8,500
0.0144%
$7.04$59,840-51.24%
2025-11-13SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
57,750
0.0892%
$5.47$315,893-41.23%
2024-12-23SaleGalectin Therapeutics Inc.
GALT
Chief Medical Officer
13,654
0.0217%
$0.88$12,044+157.27%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.